ERC -- Table of Contents (September 2006, 13 [3])

Reviews:

P Singh, A Uzgare, I Litvinov, S R Denmeade, and J T Isaacs: Combinatorial androgen receptor targeted therapy for prostate cancer; Endocr Relat Cancer 2006 13: 653-666. [Abstract] [Free Full Text] [PDF]

S M Hyder: Sex-steroid regulation of vascular endothelial growth factor in breast cancer; Endocr Relat Cancer 2006 13: 667-687. [Abstract] [Free Full Text] [PDF]

Anthony Howell: Pure oestrogen antagonists for the treatment of advanced breast cancer; Endocr Relat Cancer 2006 13: 689-706. [Abstract] [Free Full Text] [PDF]

W E Farrell: Pituitary tumours: findings from whole genome analyses; Endocr Relat Cancer 2006 13: 707-716. [Abstract] [Free Full Text] [PDF]

John P Wiebe: Progesterone metabolites in breast cancer; Endocr Relat Cancer 2006 13: 717-738. [Abstract] [Free Full Text] [PDF]

K S Kimbro and J W Simons: Hypoxia-inducible factor-1 in human breast and prostate cancer; Endocr Relat Cancer 2006 13: 739-749. [Abstract] [Free Full Text] [PDF]

Rana P Singh and Rajesh Agarwal: Mechanisms of action of novel agents for prostate cancer chemoprevention; Endocr Relat Cancer 2006 13: 751-778. [Abstract] [Free Full Text] [PDF]

Matthias Schott: Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers; Endocr Relat Cancer 2006 13: 779-795. [Abstract] [Free Full Text] [PDF]

T Kogai, K Taki, and G A Brent: Enhancement of sodium/iodide symporter expression in thyroid and breast cancer; Endocr Relat Cancer 2006 13: 797-826. [Abstract] [Free Full Text] [PDF]

Anne Kendall and Mitch Dowsett: Novel concepts for the chemoprevention of breast cancer through aromatase inhibition; Endocr Relat Cancer 2006 13: 827-837. [Abstract] [Free Full Text] [PDF]

S Fritzsche, M Kenzelmann, M J Hoffmann, M Müller, R Engers, H-J Gröne, and W A Schulz: Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma; Endocr Relat Cancer 2006 13: 839-849. [Abstract] [Full Text] [PDF]

N Sarwar, J-S Kim, J Jiang, D Peston, H D Sinnett, P Madden, J M Gee, R I Nicholson, A E Lykkesfeldt, S Shousha, R C Coombes, and S Ali: Phosphorylation of ER ${alpha}$ at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER ${alpha}$ phosphorylation in breast cancer progression; Endocr Relat Cancer 2006 13: 851-861. [Abstract] [Full Text] [PDF]

T M Sadler, M Gavriil, T Annable, P Frost, L M Greenberger, and Y Zhang: Combination therapy for treating breast cancer using antiestrogen, ERA-923, and the mammalian target of rapamycin inhibitor, temsirolimus; Endocr Relat Cancer 2006 13: 863-873. [Abstract] [Full Text] [PDF]

A Jansson, C Gunnarsson, and O Stål: Proliferative responses to altered 17ß-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors; Endocr Relat Cancer 2006 13: 875-884. [Abstract] [Full Text] [PDF]

H Yamashita, M Nishio, Y Ando, Z Zhang, M Hamaguchi, K Mita, S Kobayashi, Y Fujii, and H Iwase: Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer; Endocr Relat Cancer 2006 13: 885-893. [Abstract] [Full Text] [PDF]

J R Puddefoot, U K I Udeozo, S Barker, and G P Vinson: The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion; Endocr Relat Cancer 2006 13: 895-903. [Abstract] [Full Text] [PDF]

Yayun Liang, Rolf A Brekken, and Salman M Hyder: Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones; Endocr Relat Cancer 2006 13: 905-919. [Abstract] [Full Text] [PDF]

Daniele Generali, Stephen B Fox, Alfredo Berruti, Maria P Brizzi, Leticia Campo, Simone Bonardi, Simon M Wigfield, Paolo Bruzzi, Alessandra Bersiga, Giovanni Allevi, Manuela Milani, Sergio Aguggini, Luigi Dogliotti, Alberto Bottini, and Adrian L Harris: Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer; Endocr Relat Cancer 2006 13: 921-930. [Abstract] [Full Text] [PDF]

N Garcia de la Torre, I Buley, J A H Wass, and H E Turner: Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour; Endocr Relat Cancer 2006 13: 931-944. [Abstract] [Full Text] [PDF]

Daniela Cordella, Marina Muzza, Luisella Alberti, Paolo Colombo, Pietro Travaglini, Paolo Beck-Peccoz, Laura Fugazzola, and Luca Persani: An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma; Endocr Relat Cancer 2006 13: 945-953. [Abstract] [Full Text] [PDF]

E Ferrante, C Pellegrini, S Bondioni, E Peverelli, M Locatelli, P Gelmini, P Luciani, A Peri, G Mantovani, S Bosari, P Beck-Peccoz, A Spada, and A Lania: Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2; Endocr Relat Cancer 2006 13: 955-962. [Abstract] [Full Text] [PDF]

Sara Ekeblad, Bengt Nilsson, Margareta Halin Lejonklou, Térèse Johansson, Peter Stålberg, Ola Nilsson, Håkan Ahlman, and Britt Skogseid: Gastrointestinal stromal tumors express the orexigen ghrelin; Endocr Relat Cancer 2006 13: 963-970. [Abstract] [Full Text] [PDF]